Juvelook — hand injection, injector and device combinations
“Do you inject by hand?” is the question we hear most. But for Juvelook, which plane the product goes into and how much goes into each one matters more than hand versus machine. Here is what each of the three approaches does well, and what it cannot do. There are no prices in this column.
The short answer
Hand injection lets the plane and the volume change from area to area. An injector fills a broad surface quickly at one consistent depth. Combining Juvelook with a microneedle radiofrequency device is not injection at all — it opens channels in the skin and lays product on top, which is a different job from the other two. What matters with Juvelook is not which of the three is used but keeping the product from gathering in a superficial plane, because plane and volume are what sit closest to nodule formation. So at Miso Clinic we set the plane by hand and divide the volume where the skin is thin and mobile, such as under the eyes and around the mouth, and fill evenly across broad flat surfaces such as the cheeks. Whatever is used, a clinic should be able to tell you how superficially it went in. Miso Clinic is at 4F Bombom Building, 125 Dongdeok-ro, Jung-gu, Daegu, in front of Exit 1 of Kyungpook National University Hospital Station. +82-53-428-2700, weekdays 11:00–19:00 · Saturday 10:00–16:00 (no lunch break), closed Sundays and public holidays.
What does each of the three do?
| Approach | What it does well | Its limits |
|---|---|---|
| Hand injection (physician with a syringe) | Plane and volume can differ by area. Filling only the hollow spots is done by hand | The result depends heavily on the operator’s skill, and it takes longer |
| Injector (multi-needle systems) | Fills a broad surface quickly at a consistent depth and dose, and tends to be less painful | Depth is fixed by the machine, so changing plane area by area is difficult |
| Device combination (microneedle radiofrequency) | Opens fine channels and lays product on top, addressing texture problems such as pores and scarring at the same time | Laying product on is not the same as placing a set volume in a defined dermal plane |
The third should not be treated as interchangeable with “a Juvelook treatment”. Opening channels with a device and applying product acts close to the surface; injecting into the dermis places a defined volume in a chosen plane. Different aims, different results. If both are done, ask what was given by each route separately.
Why plane matters more than technique
Juvelook works because PDLLA microparticles remain in the skin and provoke a response there. The same volume shows and can be felt when it sits superficially, and does not when it sits deeper. That is why plane and volume take up so much room among the factors linked to nodules. The preparation side of this is covered in Juvelook hydration — why the mixing step decides whether nodules form.
| Area | What it is like | What follows |
|---|---|---|
| Under the eyes | The thinnest skin on the face, with little underneath it | Anything superficial shows immediately. Some boosters avoid this area altogether |
| Around the mouth | In motion all day | High mobility leaves more room for material to gather |
| Cheeks and temples | Broad and relatively flat | Even filling suits these surfaces well |
| Forehead | Little space under the skin, with bone close by | Smaller volumes, divided across more points |
Conditions differ from site to site within one face, so handling the whole face with a single approach is not always best. That is why we divide the face and mix approaches.
Is “hand injection is better” true?
Half true. The true half is that hand injection can change plane and volume freely, and that freedom genuinely matters in demanding areas such as under the eyes.
The untrue half is that the phrase itself guarantees nothing. Injected by hand into a plane that is too superficial, nodules still form. Delivered by an injector at a correctly set depth across a broad surface, they do not. The criterion is plane and volume, not hand versus machine.
- A face where conditions differ by area → setting each one by hand has the advantage
- Filling a broad surface evenly → consistent delivery has the advantage
- Texture, pores and scarring as the main concern → the conversation should start with devices
“We do everything by hand” is not enough to judge by. There is one more question worth asking — “which plane will you use under my eyes?”
Does combining it with a device work better?
It sounds like it could only help, so the combination is often suggested. But we have not found a comparative study showing that Juvelook plus microneedle radiofrequency does better than either alone. That is not a rejection of the combination; it is an accurate statement of how thin the evidence is.
- If texture, pores and scarring are the concern and volume loss is limited, the device may come first
- If hollowing and firmness are the concern, placing product in a plane comes first
- If both apply, we suggest separating them and watching the response rather than stacking them on one day. It keeps causes separable if something goes wrong
The more treatments are bundled into a single day, the less possible it becomes to tell what produced the benefit and what produced the problem. With an irreversible product that matters more.
What to confirm in a consultation
- Which plane is used in each area — especially under the eyes and around the mouth
- How many vials in total, and how they are divided across areas
- If a device is combined, whether the injected part and the device part are explained separately
- If other treatments are bundled on the same day, why they have to be done together
- How a nodule would be managed — this is a product with no dissolving agent
In summary — what is established and what is not
Established
- Injection plane and volume are among the factors linked to nodules
- Injector systems are designed to hold depth and dose constant
- Applying product over microneedle radiofrequency channels is a different route from placing a set volume in the dermis
Not established
- A study comparing Juvelook delivered by hand against by injector
- A comparative study showing Juvelook with microneedle radiofrequency beats either alone
- An official standard setting injection depth by facial area
Juvelook injection technique — frequently asked questions
Is hand injection better for Juvelook?
Hand injection can set plane and volume differently by area, which helps in demanding sites such as under the eyes. But injected by hand into too superficial a plane, nodules still form, and an injector set to the right depth does not cause them. The criterion is plane and volume rather than hand versus machine.
What is Juvelook injector treatment?
It is delivery by a multi-needle system that places a set depth and dose automatically. It fills broad surfaces evenly and quickly and tends to be less painful, but the depth is fixed by the machine, so changing plane area by area is difficult.
Is Juvelook better combined with a device such as microneedle radiofrequency?
Opening channels with microneedle radiofrequency and applying product on top acts close to the surface, which is a different job from placing a set volume in a dermal plane with a syringe. We have not found a comparative study showing the combination beats either alone.
Does injection technique affect nodules?
Yes. Among the factors linked to nodules, injecting too superficially and putting too much into one spot take up a large share. What matters is less the technique itself than which plane it delivered into and how much.
Can Juvelook be used under the eyes?
Under the eyes the skin is at its thinnest with little underneath, so anything superficial shows immediately. Whether to treat there at all, and in which plane, is judged by examining skin thickness and the degree of hollowing. Some boosters avoid this area.
What should I ask in a consultation?
Alongside “do you inject by hand?”, ask “which plane will you use under my eyes?” and “how many vials in total and how are they divided across areas?” Those questions reveal whether there is a plan. If a device is combined, check that the injected part and the device part are explained separately.
Can several treatments be done on the same day?
The more that are bundled, the less possible it becomes to tell what produced the benefit and what produced the problem. With an irreversible product we suggest separating them and watching the response.
Where can I discuss Juvelook injection technique in Daegu?
Miso Clinic is at 4F Bombom Building, 125 Dongdeok-ro, Jung-gu, Daegu, in front of Exit 1 of Kyungpook National University Hospital Station, and can be reached on +82-53-428-2700. We are open weekdays 11:00-19:00 and Saturday 10:00-16:00, and closed on Sundays and public holidays. Fees depend on the area and the volume used and are given by phone or at an in-person consultation.
Read next
Product reference
Product reference for this treatment: Juvelook — PDLLA skin booster. Other boosters at Miso Clinic: Rejuran · Rituo · Gouri · Collagen boosters compared
Who wrote this
This column was written and reviewed by Dr. Lee Chi-Hak, Medical Director of Miso Clinic in Daegu, South Korea. The treatment criteria and injection design are written exactly as we actually use them.
| Medical Director | Lee Chi-Hak |
|---|---|
| Address | 4F Bombom Building, 125 Dongdeok-ro, Jung-gu, Daegu, South Korea (Exit 1, Kyungpook National University Hospital Station) · Tower parking in the building |
| Phone | +82-53-428-2700 |
| KakaoTalk consultation | Miso Clinic Daegu channel |
| Opening hours | Weekdays 11:00–19:00 (lunch 13:00–14:00) / Saturday 10:00–16:00 (no lunch break) / Closed Sundays and public holidays |
| Clinical columns | See all columns |
| Reference library | All booster and lifting device references |
References
- Injection plane and nodules — In the PDLLA and PLLA family, the factors identified for nodules are insufficient reconstitution, superficial injection, local overfilling and highly mobile areas. What has been treated as the problem is the plane and volume achieved, rather than the delivery instrument itself.
- Injector delivery — Multi-needle and automated injector systems are designed to hold the set depth and delivered dose constant. Varying depth by area is constrained by that design.
- Microneedle radiofrequency with topical product — Creating channels with fine needles and applying product acts close to the surface, a different route from injecting a defined volume into a specific dermal plane with a syringe. We have not found a comparative study showing that combination with Juvelook is superior to either alone.
- Reversibility — There is no enzyme corresponding to hyaluronidase for PDLLA microparticles. Management of a nodule is mitigation rather than reversal.
- Korean medical advertising law — Medical Service Act Article 56(2) prohibits testimonial advertising, comparison with other medical institutions and superlative claims.
- Fees and patient inducement — Medical Service Act Article 45 (disclosure of non-covered fees), Article 27(3) (prohibition of patient inducement for profit) and Article 56(2). This is why no prices or discounts appear in this column.
- Miso Clinic treatment protocol — Injection plane and volume design by area, the principle of separating combined treatments, and the informed consent process. This is the source for statements marked as clinical judgement.
Everything in this column is general information and does not replace medical diagnosis or treatment. Effects and side effects vary with individual skin condition, age and underlying illness, and the same result is not guaranteed for everyone. Any decision to proceed should be made in an in-person consultation with a physician.
← Clinical columns · Reference library · Miso Clinic home
한국어 · English